The ARMS 200 provisional utility patent application filing marks the first in a series of modular systems under development at US Data Centers, Inc., including the upcoming ARMS 300 and ARMS 400 ...

As part of its ongoing effort to stop scammers from third-party trademark applications and registrations, the USPTO has enhanced security of ...

In a significant step toward modernizing design patent examination, the United States Patent and Trademark Office (USPTO) has introduced ...

On July 18, the US Patent and Trademark Office (USPTO) announced a revised practice for setting Patent Trial and Appeal Board ...

In a recently-issued Director Discretionary Denial decision, U.S. Patent and Trademark Office (USPTO) Acting Director Coke ...

Cash Position: GeoVax reported cash balances of $3,093,862 at June 30, 2025, as compared to $5,506,941 at December 31, 2024. During July 2025, the Company completed a public offering of common stock ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

We’re offering two Women of Distinction programs for fall 2025. Program I: October 17–18, 2025 Program II: November 7–8, 2025 Application opens: August 1, 2025 Application deadline: September 15, 2025 ...

Weekly Wednesday statement of assets and liabilities as required by the Bank of Canada Act. The figures for the last reference period are preliminary and are subject to revision.